Immunovant, Inc.

IMVTNASDAQHealthcare● Active

$31.15

+$0.04(+0.13%)

Market Cap$6.4B

P/E Ratio—

52W High$36.285

52W Low$14.32

Avg Volume1.8M

Open$31.69

Beta0.79

Overview

Immunovant, Inc. (IMVT) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · IMVT · as of May 20, 2026

Latest filing snapshot

315

-47-12.98%vs prior year

Immunovant, Inc. (IMVT) employee data is sourced from the annual SEC 10-K filing. As of 2026, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2026-03-31·Full-time · Global

Total Employees

315

Change (1Y)

-47

Growth % (1Y)

-12.98%

Revenue / Employee

—

Net Income / Employee

$-1.61M

Market Cap

$6.4B

IMVT Employee Count

2020 – 2026 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-05-20	2026-03-31	315	-47	-12.98%
2025-05-29	2025-03-31	362	+155	+74.88%
2024-05-29	2024-03-31	207	+43	+26.22%
2023-05-22	2023-03-31	164	+40	+32.26%
2022-06-08	2022-03-31	124	+56	+82.35%
2021-06-01	2021-03-31	68	+26	+61.90%
2020-06-29	2020-03-31	42	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ACAD

ACADIA Pharmaceuticals Inc.

653$3.7B #2

CRNX

Crinetics Pharmaceuticals, Inc.

Kymera Therapeutics, Inc.

208$6.1B #5

DYN

Dyne Therapeutics, Inc.

192$2.8B #6

AKRO

Akero Therapeutics, Inc.

69$4.5B #7

NAMS

NewAmsterdam Pharma Company N.V.

68$3.7B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · IMVT peer comparison

About IMVT employees

IMVT Employees · Headcount

Immunovant, Inc. (IMVT) employee data is sourced from the annual SEC 10-K filing. As of 2026, Immunovant, Inc. had 315 full-time employees globally. Full-time employees only. Global consolidated headcount.

Immunovant, Inc.'s workforce decreased by 47 (12.98%) in 2026 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

IMVT Employees · 5 questions

As of the latest SEC 10-K filing (2026), Immunovant, Inc. had 315 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Immunovant, Inc. employee counthow many employees does Immunovant, Inc. haveIMVT total employees 2026

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-05-20